论文部分内容阅读
本文回顾了１９７１～１９９０年在我院治疗，并有较完整随访资料的３７６例涎腺肿瘤患者的治疗情况。发生在腮腺者２６１例，颌下腺３７例，舌下腺４例，小涎腺７４例。良性肿瘤１６２例，涎腺癌２１４例；涎腺癌的病理分型：癌在多形性腺瘤中５２例，腺癌５３例，粘液表皮样癌４１例，腺泡细胞癌２７例，乳头状囊腺癌１１例，腺样囊性癌２３例，鳞状细胞癌４例，未分化癌３例。２１４例涎腺癌５年生存率为６９．６％，１０年生存率为５４．９％。良性肿瘤均手术治疗。１８２例涎腺癌采用手术或手术＋术后放疗的治疗方案。手术是治疗涎腺肿瘤的首选方法。
This article reviews the treatment of 376 cases of parotid gland tumors treated in our hospital from 1971 to 1990 and with complete follow-up data. There were 261 cases of parotid glands, 37 cases of submandibular glands, 4 cases of sublingual glands and 74 cases of small parotid glands. 162 cases of benign tumors and 214 cases of parotid adenocarcinoma; pathological classification of adenocarcinoma: 52 cases of pleomorphic adenoma, 53 cases of adenocarcinoma, 41 cases of mucoepidermoid carcinoma, 27 cases of acinar cell carcinoma, papillary There were 11 cases of cystadenocarcinoma, 23 cases of adenoid cystic carcinoma, 4 cases of squamous cell carcinoma, and 3 cases of undifferentiated carcinoma. The 5-year survival rate of 214 cases of parotid gland cancer was 69.6%, and the 10-year survival rate was 54.9%. Benign tumors are treated surgically. 182 cases of salivary gland cancer were treated with surgery or surgery plus postoperative radiotherapy. Surgery is the preferred method for treating salivary gland tumors.